Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 24Neoplasm Metastasis 5Triple Negative Breast Neoplasms 2Recurrence 2Ovarian Neoplasms 2Multiple Endocrine Neoplasia Type 1 2Lymphatic Abnormalities 2Lymphangioma, Cystic 2Lymphangioma 2Hyperglycemia 2Hereditary Sensory and Autonomic Neuropathies 2Vascular Malformations 1Squamous Cell Carcinoma of Head and Neck 1Skin Diseases, Vascular 1Melanoma 1Hormone Receptor Positive Breast Carcinoma 1Head and Neck Squamous Cell Cancer 1Head and Neck Neoplasms 1HER2-positive Metastatic Breast Cancer 1Genetic Diseases, Inborn 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Arteriovenous Malformations 1Advanced HER2+Breast Cancer 1Advanced Breast Cancer 1

Interventions

Magnetic Resonance Spectroscopy 2Waiting Lists 1Tablets 1Specimen Handling 1Fulvestrant 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Genetic Diseases, Inborn × Alpelisib × 1 year × Clear all
NCT05392608 2026-05-22

SEQUEL-Breast

Borstkanker Onderzoek Groep

Phase 2 Active not recruiting
130 enrolled
Breast

Breast Neoplasms, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon âš¡